Weare on a Mission to Transform Patients’ Lives with Revolutionary Neural-Sensing Technology F Y 2 6 R e s u l t s P r e s e n t a t i o n August 28, 2026 Important Notice & Disclaimer THIS DOCUMENT AND ITS CONTENTS ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,...
FY26 Results Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Saluda Medical
- FY26 Full Year Results
- Preliminary Final Report
- FY26 Results & Webinar, 2026 AGM Notification
- Quarterly Investor Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Saluda Medical
- Change in substantial holding
- S&P DJI Announces September 2026 Quarterly Rebalance
- CEO Transition
- FY26 Consolidated Financial Statements
- Final Director's Interest Notice - B Regan
